Thomas Cahill - Net Worth and Insider Trading
Thomas Cahill Net Worth
The estimated net worth of Thomas Cahill is at least $23 Million dollars as of 2024-11-13. Thomas Cahill is the Director of Prime Medicine Inc and owns about 5,305,679 shares of Prime Medicine Inc (PRME) stock worth over $23 Million. Details can be seen in Thomas Cahill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Cahill has not made any transactions after 2022-10-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Cahill
Thomas Cahill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Cahill owns 1 companies in total, including Prime Medicine Inc (PRME) .
Click here to see the complete history of Thomas Cahill’s form 4 insider trades.
Insider Ownership Summary of Thomas Cahill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRME | Prime Medicine Inc | 2022-10-24 | director |
Thomas Cahill Latest Holdings Summary
Thomas Cahill currently owns a total of 1 stock. Thomas Cahill owns 5,305,679 shares of Prime Medicine Inc (PRME) as of October 24, 2022, with a value of $23 Million.
Latest Holdings of Thomas Cahill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRME | Prime Medicine Inc | 2022-10-24 | 5,305,679 | 4.32 | 22,920,533 |
Holding Weightings of Thomas Cahill
Thomas Cahill Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Cahill has made a total of 1 transactions in Prime Medicine Inc (PRME) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Prime Medicine Inc is the acquisition of 400,000 shares on October 24, 2022, which cost Thomas Cahill around $7 Million.
Insider Trading History of Thomas Cahill
- 1
Thomas Cahill Trading Performance
GuruFocus tracks the stock performance after each of Thomas Cahill's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Cahill is 10.92%. GuruFocus also compares Thomas Cahill's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Cahill within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas Cahill's insider trading performs compared to the benchmark.
Performance of Thomas Cahill
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 29.54 | | | | | |
| Relative Return to S&P 500(%) | 23.49 | | | | | |
Thomas Cahill Ownership Network
Ownership Network List of Thomas Cahill
Ownership Network Relation of Thomas Cahill
Thomas Cahill Owned Company Details
What does Prime Medicine Inc do?
Who are the key executives at Prime Medicine Inc?
Thomas Cahill is the director of Prime Medicine Inc. Other key executives at Prime Medicine Inc include director & 10 percent owner Robert Nelsen , 10 percent owner Arch Venture Partners X, Llc , and 10 percent owner Gv 2019 Gp, L.l.c. .
Prime Medicine Inc (PRME) Insider Trades Summary
Over the past 18 months, Thomas Cahill made no insider transaction in Prime Medicine Inc (PRME). Other recent insider transactions involving Prime Medicine Inc (PRME) include a net sale of 886,157 shares made by Gv 2019 Gp, L.l.c. , a net purchase of 3,200,000 shares made by Robert Nelsen , and a net purchase of 3,200,000 shares made by Arch Venture Partners X, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Prime Medicine Inc (PRME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 886,157 shares of Prime Medicine Inc (PRME) were sold and 9,600,000 shares were bought by its insiders, resulting in a net purchase of 8,713,843 shares.
Prime Medicine Inc (PRME)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prime Medicine Inc Insider Transactions
Thomas Cahill Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Cahill. You might contact Thomas Cahill via mailing address: Prime Medicine, Inc., 21 Erie St., Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
